Laman UtamaIMRSQ • OTCMKTS
add
IMRIS Ord Shs
Tutup sebelumnya
$0.00
Bilangan Purata
372.00
Nisbah P/E
-
Hasil dividen
-
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(USD) | 2014info | Perubahan T/T |
---|---|---|
Hasil | 28.89J | — |
Perbelanjaan pengendalian | 33.07J | — |
Pendapatan bersih | -30.39J | — |
Margin untung bersih | -105.18 | — |
Pendapatan bagi setiap syer | -0.58 | 30.12% |
EBITDA | -20.30J | — |
Kadar cukai berkesan | -0.80% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(USD) | 2014info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 5.00J | — |
Jumlah aset | 65.48J | — |
Jumlah liabiliti | 53.69J | — |
Jumlah ekuiti | 11.79J | — |
Syer tertunggak | 62.59J | — |
Harga kepada buku | 0.00 | — |
Pulangan pada aset | -19.15% | — |
Pulangan pada modal | -31.61% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(USD) | 2014info | Perubahan T/T |
---|---|---|
Pendapatan bersih | -30.39J | — |
Tunai daripada operasi | -10.91J | — |
Tunai daripada pelaburan | 4.49J | — |
Tunai daripada pembiayaan | 3.50J | — |
Perubahan bersih dalam tunai | -1.38J | — |
Aliran tunai bebas | 4.58J | — |
Perihal
IMRIS, founded in 2005, is a global provider of intraoperative imaging solutions.
The company's flagship product is the IMRIS Surgical Theatre. A hybrid operating theatre with intraoperative imaging capabilities, The IMRIS Surgical Theatre incorporates design and technology provided by IMRIS, including the moveable intraoperative MRI, as well as technology from 3rd-party medical device companies. IMRIS designs, creates and supports the IMRIS Surgical Theatre, which the company's marketing materials describe as "the world's most advanced hybrid operating theatre." Wikipedia
Diasaskan
2005
Ibu pejabat
Tapak web
Pekerja
121